Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Predictors of treatment outcomes for trauma-affected refugees - results from two randomised trials

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A Rasch-based validity study of the Harvard Trauma Questionnaire

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Data-Driven Model Building for Life Course Epidemiology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Age at Onset and Age at Treatment of Alcohol Use Disorders: Associations with Educational Level and Intelligence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: To describe treatment patterns in patients with treatment-resistant depression (TRD) and major depressive disorder (MDD) stratified by depression severity and year of diagnosis. Patterns of treatment were also compared to country-specific guidelines.

METHODS: All adults registered first time with a hospital contact due to MDD from 1996 through 2015 were identified and followed for all dispensed prescriptions of antidepressants, antipsychotics, lithium, initiation of electroconvulsive therapy (ECT), and psychotherapy in Danish registers 12 months before and after their hospital MDD diagnosis. TRD was characterized by two shifts in treatment.

RESULTS: We identified 197,615 patients of whom 15% developed TRD. In total, 88% of patients started treatment with antidepressants or ECT. Selective serotonin reuptake inhibitors (SSRIs) were the most frequently used treatment during the study period and more than half (50.7%) of patients changed treatment at least once. Among patients with TRD, serotonin and noradrenaline reuptake inhibitors (SNRIs) were the most frequently used treatment (55.9%), and 37.0% initiated a new treatment the following year. SSRIs and SNRIs were part of most combinations of treatment, regardless of depression severity, year of diagnosis, or presence of TRD.

CONCLUSION: 15% of patients met the criteria for TRD. Irrespective of patient characteristics and year of diagnosis, SSRIs and SNRIs are the most used treatments for depression, even after patients met the criteria for TRD. We confirm that guidelines for first treatment were followed for most patients diagnosed with MDD in Denmark, but for patients with TRD, choice of treatment was arbitrary.

OriginalsprogEngelsk
TidsskriftJournal of Affective Disorders
Vol/bind287
Sider (fra-til)204-213
Antal sider10
ISSN0165-0327
DOI
StatusUdgivet - 15 maj 2021

ID: 64729193